$2.03
+0.13 (+6.84%)
Open$1.93
Previous Close$1.90
Day High$2.10
Day Low$1.91
52W High$23.43
52W Low$1.90
Volume—
Avg Volume101.7K
Market Cap26.64M
P/E Ratio—
EPS$-7.19
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 21.98M | 69.23M | 31.57M |
| Net Income | -94,386,393 | -267,551,980 | 932.2K |
| Profit Margin | -429.4% | -408.0% | 3.0% |
| EBITDA | -62,624,643 | -187,380,821 | 1.58M |
| Free Cash Flow | — | — | 483.5K |
| Rev Growth | -68.3% | -68.3% | +6.0% |
| Debt/Equity | 0.19 | 0.19 | 0.73 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |